MIM
PAVM icon

MetLife Investment Management’s PAVmed PAVM Stock Holding History

MetLife Investment Management’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-40
Closed -$152K – 2539
2021
Q3 		$152K Sell
40
-24
-38% -$75.7K ﹤0.01% 2250
2021
Q2 		$183K Buy
+64
New +$151K ﹤0.01% 2224

Other funds holding PAVM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

MetLife Investment Management's PAVM Position: Q4 2021 in Review

MetLife Investment Management sold out of PAVmed (PAVM) in Q4 2021, closing a stake of 40 shares — an estimated $152K sold.

MetLife Investment Management first reported a position in PAVM in Q2 2021 and held it in 2 quarters. The position peaked at $183K in Q2 2021. 105 funds tracked by Wall St. Rank hold PAVM as of Q4 2021.

  • MetLife Investment Management reported no remaining PAVmed position as of Q4 2021 after selling out during the quarter.
  • MetLife Investment Management sold 40 PAVmed shares in Q4 2021, an estimated $152K.
  • MetLife Investment Management first reported a position in PAVmed in Q2 2021 and held it in 2 quarters.
  • MetLife Investment Management's PAVmed position peaked at $183K in Q2 2021.
  • 105 funds tracked by Wall St. Rank held PAVmed as of Q4 2021.

Based on MetLife Investment Management's 13F filing for Q4 2021, filed 15 Feb 2022.